viral
diseas
widespread
throughout
world
rang
minor
infect
plagu
alter
cours
histori
burden
diseas
induc
viral
infect
enorm
deadli
infecti
diseas
caus
viral
infect
among
virus
coronavirus
cov
subfamili
coronavirina
famili
coronavirida
order
nidoviral
repres
major
group
virus
known
respons
respiratori
enter
hepat
neurolog
diseas
multipl
speci
pene
et
al
woo
et
al
chan
et
al
cov
affect
human
popul
refer
human
coronavirus
hcov
lead
multipl
respiratori
diseas
common
cold
pneumonia
bronchiti
lim
et
al
centuri
seen
rapid
evolut
hcov
contributori
factor
urban
poultri
farm
factor
allow
cross
speci
barrier
genom
recombin
virus
jone
et
al
six
hcov
identifi
far
name
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
latter
four
virus
mainli
respons
onethird
common
cold
infect
human
sever
case
lead
lifethreaten
pneumonia
bronchiti
partial
overlap
open
read
frame
within
twothird
part
cov
genom
constitut
larg
replicas
gene
entri
virion
host
cell
replicas
gene
translat
produc
fig
polyprotein
cleav
papainlik
cystein
proteas
plpro
serin
proteasemain
proteas
mpro
produc
nonstructur
protein
nsp
produc
nsp
produc
nsp
mani
nsp
assembl
rtc
creat
viabl
suitabl
environ
rna
synthesi
lead
replic
transcript
subgenom
rna
lim
et
al
shi
et
al
apart
rdrp
nsp
code
replicas
gene
also
play
crucial
role
cov
replic
transcript
encod
rdrp
domain
encod
helicas
hel
domain
remain
nsp
encod
enzym
domain
protein
proteinas
put
rna
primas
superfamili
helicas
exoand
endoribonucleas
singlestrand
rna
ssrna
bind
protein
two
methyltransferas
adedeji
et
al
subissi
et
al
snijder
et
al
onethird
part
cov
genom
subgenom
sequenc
encod
structur
protein
ie
spike
protein
envelop
protein
e
membran
protein
nucleocapsid
protein
n
essenti
viru
cellreceptor
bind
virion
assembl
nsp
accessori
protein
may
immunomodulatori
effect
ying
et
al
region
transcrib
complex
follow
translat
mrna
produc
respect
protein
fig
lim
et
al
rdrp
central
catalyt
subunit
rnasynthes
machineri
cov
usual
rdrp
domain
readili
identifi
compar
sequenc
analysi
howev
biochem
character
hinder
intrins
protein
properti
technic
complic
wellknown
fact
replic
transcript
kb
cov
rna
genom
catalyz
rdrp
domain
ctermin
part
one
replicas
subunit
imbert
et
al
sexton
et
al
howev
thu
far
fulllength
proven
refractori
express
bacteri
system
hinder
biochem
character
coronaviru
rna
synthesi
rdrptarget
antivir
drug
design
interestingli
sarscov
second
protein
rdrp
activ
identifi
enzym
capabl
de
novo
initi
propos
oper
primas
interestingli
protein
crystal
togeth
form
hexadecamer
dsrnaencircl
ring
structur
ie
nsp
consist
eight
copi
nsp
te
two
decad
ago
sequenc
analysi
first
cov
genom
perform
recent
compar
sequenc
analysi
allow
identif
put
rdrp
domain
cov
rtc
boursnel
et
al
gorbalenya
et
al
te
velthui
et
al
ctermin
ie
twothird
subunit
known
success
align
conserv
motif
alreadi
known
rdrp
gorbalenya
et
al
xu
et
al
unpreced
size
among
viral
rdrp
subunit
commonli
amino
acid
suggest
may
possess
function
domain
yet
uncharacter
ntermin
domain
ntd
biochem
inform
cov
rdrp
howev
remain
scarc
far
particularli
fulllength
refractori
express
bacteri
system
preliminari
evid
vitro
rdrp
activ
came
studi
sarscov
enzym
cheng
et
al
experi
involv
use
glutathion
stransferas
gst
fusion
protein
howev
protein
instabl
protein
fragment
three
part
hamper
studi
studi
also
led
identif
primerdepend
activ
poli
templat
use
filterbind
assay
howev
enzym
biochemistri
analyz
detail
cheng
et
al
given
pivot
role
viral
replic
efficaci
polymeras
structur
hcov
rdrp
inhibitor
use
combat
viru
infect
rdrp
wide
regard
import
attract
target
ration
design
anticov
drug
xu
et
al
de
clercq
therefor
sever
research
group
tri
solv
technic
issu
involv
stabl
express
purif
vitro
activ
fulllength
cov
reason
success
achiev
develop
method
gener
recombin
protein
contain
natur
nterminu
found
critic
step
road
toward
purif
stabl
recombin
cov
rdrp
te
velthui
et
al
howev
homolog
model
sarscov
rdrp
attempt
base
conserv
sequenc
motif
reliabl
sequenc
align
threedimension
homolog
model
catalyt
domain
sarscov
rdrp
develop
xu
et
al
fig
homolog
model
base
crystal
structur
polioviru
strain
mahoney
pdb
code
rabbit
hemorrhag
diseas
viru
rhdv
pdb
code
hepat
c
viru
hcv
pdb
code
reoviru
rv
pdb
code
bacteriophag
pdb
code
rt
pdb
code
homolog
model
sarscov
rdrp
show
presenc
catalyt
domain
consist
finger
palm
thumb
figur
ribbon
diagram
homolog
model
sever
acut
respiratori
syndrom
coronaviru
rnadepend
rna
polymeras
sarscov
rdrp
shown
spiral
arrow
catalyt
domain
ntermin
portion
finger
subdomain
shown
blue
base
finger
red
palm
yellow
thumb
green
sourc
reprint
xu
x
liu
weiss
arnold
e
sarafiano
sg
ding
j
subdomain
form
encircl
nucleic
acidbind
tunnel
fig
structur
analysi
model
provid
critic
inform
potenti
function
role
conserv
motif
specif
residu
polymer
tabl
sarscov
rdrp
contain
ntd
approxim
residu
expect
form
least
one
protein
domain
covspecif
replicas
transcript
activ
may
associ
region
domain
may
involv
interact
leader
intragen
sequenc
transcript
characterist
nest
mrna
sarscov
cov
andor
interact
involv
viral
hel
viral
andor
host
protein
involv
viru
replic
tao
et
al
sequenc
structur
finger
subdomain
less
conserv
palm
subdomain
among
differ
viral
rdrp
finger
subdomain
sarscov
rdrp
extend
approxim
residu
consist
two
polypeptid
segment
ntermin
segment
segment
cover
motif
b
palm
subdomain
finger
subdomain
predict
differ
secondari
structur
composit
base
tip
finger
base
consist
tip
consist
coil
fig
two
conserv
sequenc
motif
f
g
also
present
sar
cov
model
motif
play
import
function
role
mechan
polymer
butcher
et
al
tao
et
al
finger
subdomain
sarscov
rdrp
compris
ntermin
portion
residu
form
long
loop
origin
fingertip
bridg
finger
thumb
subdomain
fig
interact
encircl
nucleic
acidbind
tunnel
form
accommod
bind
transloc
nucleic
acid
without
major
conform
chang
enzym
interact
subdomain
suppos
play
critic
role
movement
modul
initi
elong
termin
rna
synthesi
ensur
high
process
butcher
et
al
tao
et
al
ntermin
region
finger
subdomain
also
suggest
involv
recognit
nucleotid
substrat
interact
oligomer
polymeras
hobson
et
al
pathak
et
al
bruenn
motif
f
propos
consist
two
submotif
bruenn
sarscov
rdrp
motif
contain
sever
highli
conserv
basic
residu
includ
motif
contain
residu
tabl
structur
model
sarscov
rdrp
residu
motif
f
also
predict
form
part
ribonucleosid
triphosph
rntp
bind
pocket
help
posit
templat
overhang
tabl
anoth
motif
g
also
found
sarscov
correspond
residu
predict
involv
posit
templat
strand
structur
model
sarscov
rdrp
tabl
howev
palm
subdomain
sarscov
rdrp
residu
import
structur
element
polymeras
activ
constitut
catalyt
core
polymeras
compris
five
highli
conserv
sequenc
motif
poch
et
al
core
structur
palm
subdomain
includ
central
threestrand
flank
two
one
side
fig
residu
form
catalyt
activ
site
found
within
motif
c
motif
sarscov
rdrp
contain
two
highli
conserv
aspart
acid
residu
separ
four
residu
tabl
motif
consist
short
structur
motif
along
motif
c
form
central
fig
first
aspart
along
two
aspart
motif
c
form
catalyt
core
sarscov
rdrp
fig
correspond
three
aspart
probabl
involv
bind
dival
metal
ion
requir
catalysi
bees
steitz
huang
et
al
butcher
et
al
bressanelli
et
al
tao
et
al
mutat
aspart
sarscov
rdrp
expect
annul
polymeras
activ
motif
rdrp
also
expect
involv
sugar
select
tabl
motif
b
sarscov
rdrp
form
loop
structur
contain
sever
highli
conserv
residu
appear
particip
recognit
correct
nucleic
acid
select
correct
substrat
tabl
conserv
sequenc
motif
highlight
dock
rntp
substrat
shown
ballandstick
model
catalyt
activ
site
defin
three
conserv
aspart
shown
side
chain
coordin
two
dival
metal
ion
shown
magenta
sphere
sourc
reprint
xu
x
liu
weiss
arnold
e
sarafiano
sg
ding
j
molecular
model
sar
coronaviru
polymeras
implic
biochem
function
drug
design
nucleic
acid
re
open
access
public
ntermin
loop
motif
b
contain
three
conserv
residu
seem
interact
nucleotid
form
basepair
incom
rntp
ago
et
al
butcher
et
al
ng
et
al
tao
et
al
part
motif
b
along
form
motif
stack
beneath
central
conserv
asparagin
motif
b
consid
contribut
specif
rdrp
rntp
versu
deoxyribos
nucleosid
triphosph
dntp
propos
due
hydrogenbond
second
conserv
aspart
motif
turn
hydrogenbond
rntp
sarscov
rdrp
seen
tabl
motif
b
appear
interact
motif
hydrogen
bond
thu
like
play
similar
role
ie
help
sugar
select
rntp
sarscov
rdrp
contain
highli
conserv
motif
c
activ
site
motif
form
turn
hairpin
structur
two
conserv
aspart
locat
turn
fig
first
leucin
invari
cov
rdrp
appar
function
role
molecular
model
sarscov
rdrp
molecular
model
sarscov
rdrp
possibl
role
assist
posit
terminu
andor
prime
nucleotid
tabl
motif
along
two
aspart
motif
c
form
activ
site
sarscov
rdrp
role
first
aspart
coordin
metal
ion
catalysi
bees
steitz
huang
et
al
butcher
et
al
bressanelli
et
al
tao
et
al
primari
sequenc
motif
well
conserv
alway
form
turn
short
known
rdrp
motif
flank
central
contain
catalyt
aspart
exact
function
role
motif
yet
clear
like
motif
involv
stabil
core
structur
catalyt
domain
help
posit
motif
viral
rdrp
includ
sarscov
rdrp
tabl
primari
sequenc
motif
e
also
well
conserv
fig
poch
et
al
motif
e
conserv
turn
structur
motif
e
locat
intersect
palm
thumb
subdomain
propos
role
control
flexibl
thumb
dna
polymer
jacobomolina
et
al
ding
et
al
huang
et
al
molecular
model
sarscov
rdrp
motif
e
compris
residu
residu
turn
assist
posit
primer
strand
polymeras
activ
site
therebi
contribut
fidel
polymer
process
tabl
ctermin
region
sarscov
rdrp
residu
compris
thumb
subdomain
sequenc
thumb
subdomain
less
conserv
polymeras
conform
thumb
subdomain
sarscov
rdrp
leav
nucleic
acid
cleft
unobstruct
allow
entri
doublestrand
rna
dsrna
structur
inform
sarscov
rdrp
avail
homolog
model
describ
reveal
critic
inform
extend
gener
hcov
rdrp
inhibit
hcov
rdrp
potenti
pharmacolog
intervent
therapi
diseas
caus
hcov
infect
structur
inform
use
design
develop
mani
small
molecul
inhibitor
hcov
rdrp
howev
success
direct
still
demand
inform
cov
rdrp
viru
life
cycl
involv
transcript
genom
mrna
translat
viral
protein
synthesi
ident
copi
genom
encapsid
newli
assembl
viru
capsid
virus
spend
entir
life
cycl
host
cell
cytoplasm
thu
access
host
polymeras
thu
must
encod
polymeras
transcript
replic
base
type
genom
replic
strategi
need
transcript
virus
classifi
seven
class
base
function
viral
polymeras
classifi
four
class
ie
dnadepend
dna
polymeras
dddp
dnadepend
rna
polymeras
ddrp
rdrp
rnadepend
dna
polymeras
rddp
revers
transcriptas
rdrp
revers
transcriptas
uniqu
viru
host
cell
need
replic
rna
perform
revers
transcript
polymeras
present
host
cell
cov
rna
virus
use
rdrp
replic
well
transcript
genom
rdrp
perform
basic
function
viral
polymeras
ie
copi
nucleic
acid
templat
strand
yield
daughter
strand
activ
involv
transfer
nucleotidyl
moieti
incom
ntp
complementari
templat
strand
grow
daughter
strand
dna
rna
polymeras
activ
requir
two
dival
metal
cation
ie
mg
mn
polymeras
activ
site
consist
bind
site
templat
strand
primer
incom
ntp
reaction
step
includ
bind
ntp
incorpor
nucleosid
monophosph
grow
daughter
strand
releas
pyrophosph
transloc
templat
strand
grow
daughter
strand
site
site
metal
ion
bound
aspart
residu
play
role
facilit
reaction
termin
rna
dna
primer
alpha
phosphat
group
incom
nucleotid
bind
increas
nucleophil
posit
incom
ntp
bind
phosphat
stabil
pyrophosph
leav
group
among
rdrp
cov
one
well
studi
term
mechan
action
sarscov
two
replicas
subunit
rdrp
activ
believ
involv
replic
sarscov
genom
first
one
second
one
involv
discuss
previous
rna
genom
replic
crucial
step
sarscov
propag
mediat
rna
replicas
compos
viral
nsp
host
protein
sarscov
first
protein
encod
gener
cleavag
plpro
consid
catalyt
core
rna
replicas
due
presenc
sdd
motif
common
coronaviru
rdrp
oh
ahn
synthesi
viral
genom
subgenom
initi
rna
synthesi
end
viral
genom
subgenom
plu
minu
sens
selisko
et
al
correct
initi
synthesi
rna
crucial
mainten
viral
genom
integr
gener
rna
virus
util
two
mechan
initi
rna
synthesi
de
novo
initi
primerdepend
initi
kao
et
al
de
novo
initi
start
nucleotid
provid
hydroxyl
group
addit
next
nucleotid
wherea
primerdepend
initi
separ
oligonucleotid
protein
primer
requir
provid
hydroxyl
nucleophil
master
possibl
belong
sarscov
rdrp
primerdepend
polymeras
class
justifi
presenc
g
motif
signatur
exist
primerdepend
rdrp
implic
recognit
rna
complex
central
domain
structur
sarscov
studi
ahn
cowork
propos
sarscov
use
primerdepend
primerindepend
rna
synthesi
activ
ahn
et
al
studi
character
biochem
properti
fulllength
sarscov
initi
de
novo
rna
synthesi
use
viral
rna
templat
correspond
end
plu
minu
strand
sarscov
genom
addit
map
minim
cisact
region
requir
initi
synthesi
plu
minu
rna
strand
result
studi
conclud
need
small
region
less
nucleotid
termini
viral
genom
complementari
minusstrand
rna
initi
rna
synthesi
poli
tail
end
viral
genom
play
regulatori
role
initi
rna
synthesi
minusstrand
rna
synthesi
purin
nucleotid
preferenti
use
de
novo
initi
rna
synthesi
ahn
et
al
structur
studi
pv
rdrp
reveal
nativ
nterminu
consid
essenti
proper
fold
finger
subdomain
locat
activ
site
addit
residu
even
singl
methionin
residu
ad
neg
affect
activ
enzym
gohara
et
al
thompson
peersen
find
propos
addit
ntermin
might
hinder
proper
fold
sarscov
rdrp
thu
caus
subsequ
degrad
te
velthui
et
al
te
velthui
et
al
tri
qualit
assess
polymeras
activ
develop
reliabl
protocol
success
express
purif
vitro
activ
stabl
saracov
te
velthui
et
al
first
part
studi
involv
descript
combin
strategi
involv
bacteri
express
fusion
protein
vivo
cleavag
ubiquitin
carboxyltermin
hydrolas
recogn
cleavag
site
locat
ubiquitin
ub
moieti
nterminu
proteolyt
cleavag
fusion
protein
gener
purifi
stabl
sarscov
contain
natur
nterminu
second
part
studi
aartjan
et
al
assess
polymeras
activ
monitor
incorpor
nucleotid
synthet
rna
templat
extens
primer
observ
incorpor
p
atp
extens
plabel
primer
sequenc
align
sarscov
known
structur
rdrp
reveal
residu
canon
aspart
acid
respons
coordin
dival
cation
activ
site
rdrp
viral
rdrp
substitut
equival
residu
asparagin
alanin
result
chang
abolish
activ
polymeras
order
obtain
activ
site
mutant
could
use
neg
control
aartjan
et
al
engin
mutant
mutant
protein
show
residu
primer
extens
activ
therefor
confirm
natur
rdrp
activ
support
previou
hypothesi
residu
essenti
player
activ
site
enzym
te
velthui
et
al
second
polymeras
involv
replic
sarscov
genom
small
protein
uniqu
cov
report
capabl
synthes
rna
de
novo
low
fidel
ssrna
templat
form
hexadecamer
ring
structur
resid
immedi
upstream
replicas
polyprotein
precursor
would
serv
rna
primas
synthes
short
oligonucleotid
would
act
primer
subsequ
extens
imbert
et
al
format
complex
boost
rdrp
activ
increas
rna
bind
marcott
et
al
te
velthui
et
al
te
velthui
et
al
demonstr
hexadecam
probabl
conform
second
sarscov
polymeras
te
tri
find
whether
dsrnabind
channel
complex
play
role
rdrp
activ
whether
activ
influenc
imbert
et
al
therefor
gener
purifi
recombin
form
sarscov
complex
natur
ntermin
residu
find
prove
exposur
natur
nterminu
crucial
enzymat
activ
complex
partial
dsrna
templat
demonstr
complex
multimer
rna
polymeras
capabl
primer
extens
well
activ
weaker
primerdepend
rdrp
equal
monom
concentr
moreov
perform
sitedirect
mutagenesi
identifi
residu
may
contribut
catalyt
center
complex
polymeras
effort
result
two
observ
mutat
conserv
ntermin
dexd
motif
includ
sarscov
residu
abolish
polymeras
activ
mutat
ctermin
motif
compris
sarscov
affect
rdrp
activ
primer
extens
activ
sever
affect
presenc
ntermin
extens
ie
ubiquitin
due
chang
oligomer
state
strong
activ
complex
indic
activ
unlik
directli
control
ntermin
cleavag
event
observ
pv
polymeras
marcott
et
al
observ
propos
divers
array
rdrp
may
involv
cov
transcript
replic
te
mechan
transcript
replic
sarscov
understood
complex
zhai
et
al
present
crystal
structur
hexadecamer
supercomplex
sarscov
resolut
zhai
et
al
structur
supercomplex
display
atom
interact
cov
nsp
architectur
cov
replic
transcript
machineri
experi
propos
supercomplex
could
encircl
rna
function
gener
process
factor
rdrp
supercomplex
hollow
cylinderlik
structur
central
channel
assembl
eight
copi
bound
tightli
togeth
eight
copi
role
supercomplex
bind
nucleic
acid
phosphat
backbon
nucleic
acid
pass
channel
without
electrostat
repuls
inner
channel
complex
posit
potenti
outer
surfac
cover
neg
potenti
cov
replic
take
place
cytoplasm
infect
cell
dna
involv
therefor
presenc
dsrna
intermedi
import
genom
replic
cov
rna
synthesi
zhai
et
al
enjuan
et
al
van
hemert
et
al
function
hollow
cylindr
structur
hexadecam
encircl
stabil
dsrna
hold
nascent
templat
strand
togeth
transcript
replic
high
conserv
cov
indic
gener
compon
cov
thu
structur
function
analysi
saracov
complex
might
enabl
scientist
decod
mechan
sarscov
genom
replic
even
use
develop
new
strategi
prevent
treatment
sar
anim
human
zhai
et
al
te
velthui
et
al
discuss
previous
major
lifethreaten
hcov
infect
sar
mer
thu
discuss
section
includ
current
therapi
sar
mer
primari
focu
rdrp
inhibitor
present
specif
antivir
therapi
vaccin
proven
effect
treat
prevent
hcov
infect
geller
et
al
numer
test
compound
exhibit
effect
inhibit
entri
replic
sarscov
cell
cultur
anim
model
fail
random
placebo
control
trial
epidem
sarscov
variou
approach
use
none
found
success
sinc
research
conduct
discov
effect
therapeut
agent
sarscov
infect
base
understand
virolog
cov
current
clinic
manag
strategi
sar
support
care
involv
organ
support
prevent
complic
includ
organ
failur
acut
respiratori
distress
syndrom
secondari
nosocomi
infect
cheng
et
al
chan
et
al
zumla
et
al
hcov
known
sar
epidem
two
virus
caus
selflimit
upper
respiratori
tract
infect
sarscov
suddenli
emerg
research
especi
involv
antivir
research
well
prepar
improv
sar
treatment
depend
identifi
effect
antivir
viral
load
suppress
thu
three
gener
approach
use
identifi
potenti
antivir
treatment
hcov
infect
barnard
kumaki
kilianski
baker
first
fastest
approach
drug
discoveri
test
drug
broadspectrum
antivir
activ
use
treat
cov
associ
human
infect
numer
agent
identifi
approach
includ
interferon
alpha
beta
gamma
ribavirin
cyclophilin
inhibitor
de
wild
et
al
falzarano
et
al
frausto
et
al
chan
et
al
zumla
et
al
second
drug
discoveri
approach
identifi
antivir
sar
involv
screen
chemic
librari
compris
numer
exist
compound
databas
contain
inform
transcript
signatur
differ
cell
line
variou
class
drug
identifi
approach
includ
affect
neurotransmitt
regul
kinas
signal
protein
process
estrogen
receptor
lipid
metabol
dna
synthesi
repair
de
wild
et
al
elshabrawi
et
al
third
approach
identifi
treatment
sar
includ
de
novo
develop
specif
antivir
agent
base
viral
genom
structur
biolog
individu
cov
develop
candid
drug
timeconsum
first
two
approach
mani
viral
inhibitor
identifi
method
includ
mab
target
host
receptor
sirna
inhibitor
target
specif
viral
enzym
involv
viral
replic
cycl
inhibitor
viru
endocytosi
host
cell
inhibitor
host
cellular
proteas
jiang
et
al
tang
et
al
ying
et
al
chan
et
al
despit
high
speci
divers
cov
common
genom
element
import
develop
new
therapeut
agent
larg
replicas
polyprotein
cleav
two
viral
proteas
proteas
papainlik
proteas
produc
nsp
ie
rdrp
hel
rdrp
essenti
part
cov
complex
involv
product
genom
rna
rdrp
well
hel
key
target
develop
potent
anticov
drug
strong
bind
chemic
target
protein
viru
disrupt
viral
cell
cycl
reduc
viral
infect
van
boheemen
et
al
chan
et
al
wellknown
broadspectrum
antivir
agent
proven
viru
inhibit
activ
ribavirin
purin
nucleosid
analog
although
mechan
action
still
debat
issu
block
replic
variou
rna
dna
virus
inhibit
inosin
monophosph
imp
dehydrogenas
key
enzym
involv
guanosin
triphosph
gtp
biosynthesi
ribavirin
also
inhibit
viral
rdrp
activ
block
mrna
cap
induct
mutat
rnadepend
viral
replic
howev
ribavirin
show
signific
activ
sarscov
replic
cell
cultureit
requir
inhibitori
concentr
much
higher
need
inhibit
virus
ml
thu
appear
repres
viabl
treatment
option
howev
high
dose
ribavirin
use
treat
sar
patient
clinic
applic
limit
due
sever
side
effect
associ
high
dose
booth
et
al
lee
et
al
de
clercq
cheng
et
al
peter
et
al
notwithstand
proteas
protein
limit
studi
small
molecul
inhibitor
rdrp
critic
viral
rna
replic
insid
host
cell
avail
yap
et
al
experiment
shown
aurintricarboxyl
acid
ata
could
select
inhibit
sarscov
replic
insid
host
cell
lead
viral
mrna
transcript
product
less
untreat
control
yap
et
al
possibl
relat
inhibit
sarscov
rdrp
anand
et
al
bermejo
martin
et
al
koren
et
al
et
al
yap
et
al
studi
yap
et
al
incorpor
multipl
bioinformat
tool
investig
potenti
bind
modessit
ata
rdrp
sarscov
pathogen
positivestrand
rna
virus
well
sever
protein
posit
control
use
studi
constitut
three
protein
crystal
structur
avail
ca
activ
neutral
proteas
mcalpain
protein
tyrosin
phosphatas
ptp
yersinia
pesti
hiv
integras
eight
region
homolog
obtain
protein
interest
r
bind
one
region
locat
palm
subdomain
sarscov
rdrp
predict
molecular
dock
studi
import
bind
motif
recogn
ata
cushman
sherman
posner
et
al
liang
et
al
sun
et
al
yap
et
al
result
experi
show
ata
could
bind
rdrp
well
protein
sarscov
inhibit
activ
incorpor
bind
motif
catalyt
domain
specif
protein
inhibitori
bind
mechan
especi
rdrp
could
explain
mrna
transcript
reduc
sarsinfect
cell
cultur
treat
ata
compar
untreat
control
thu
ata
could
develop
potent
antivir
drug
target
replic
machineri
possibl
larg
group
positivestrand
rna
virus
yap
et
al
anoth
approach
inhibit
hcov
rdrp
identifi
base
develop
seri
doubli
flexibl
nucleosid
analog
analog
base
flexibl
acycl
sugar
scaffold
acyclovir
acv
flexbas
motif
found
flexim
inhibit
rdrp
doubli
flexibl
nucleosid
analog
evalu
antivir
activ
view
novel
class
drug
candid
potenti
inhibit
sever
cov
flexim
uniqu
nucleosid
analog
possess
purin
base
scaffold
pyrimidin
imidazol
ring
attach
singl
bond
instead
fuse
like
typic
purin
design
analog
retain
essenti
purin
hydrogenbond
pattern
well
allow
nucleobas
explor
altern
bind
mode
analog
sever
advantag
includ
bind
affin
atyp
enzym
abil
overcom
resist
caus
point
mutat
biolog
import
bind
site
increas
bind
affin
compar
inhibitor
peter
et
al
describ
design
synthesi
preliminari
screen
new
class
nucleosid
analog
flexbas
modif
flexim
combin
acycl
sugar
scaffold
acv
nucleosid
polymeras
inhibitor
fig
peter
et
al
acv
approv
treatment
varicella
zoster
viru
vzv
herp
simplex
viru
hsv
infect
also
activ
human
immunodefici
viru
suppress
replic
well
submicromolar
rang
concentr
lymphoid
cervicovagin
human
tissu
peter
et
al
design
acv
analog
hope
would
possess
biolog
activ
peter
et
al
result
studi
acycl
flexim
nucleosid
analog
could
block
replic
merscov
cell
cultur
micromolar
concentr
effect
sarscov
mcguirt
furman
furman
et
al
vanpouil
et
al
peter
et
al
addit
nucleosid
analog
inhibitor
rdrp
regul
gene
express
small
interfer
rna
sirna
use
inhibit
hcov
vitro
abil
sirna
silenc
express
specif
gene
provid
novel
approach
treat
variou
human
diseas
explor
abil
sirna
interrupt
replic
sarscov
specif
sirna
synthes
introduc
mammalian
cell
sirna
target
viral
spike
rdrp
envelop
protein
nucleocapsid
result
show
antisar
sirna
inhibit
viral
gene
express
find
suggest
novel
approach
inhibit
product
viral
protein
lead
treatment
sar
meng
et
al
bitko
barik
two
approach
produc
sirna
mammalian
cell
first
control
specif
promot
form
doublestrand
sirna
second
hairpin
structur
sirna
express
hairpin
structur
subsequ
process
sirna
intracellularli
meng
et
al
employ
approach
produc
sever
sirna
molecul
test
sarscov
rdrp
envelop
e
protein
meng
et
al
studi
cellbas
assay
develop
screen
sirna
inhibit
express
two
gene
encod
envelop
e
protein
rdrp
sarscov
envelop
e
protein
play
import
role
envelop
format
viru
assembl
rdrp
essenti
viral
rna
replic
envelop
e
rdrp
gene
synthes
base
publish
sequenc
clone
mammalian
express
vector
two
sirna
site
envelop
e
gene
four
sirna
site
rdrp
gene
design
test
addit
sirna
short
hairpin
rna
shrna
express
cassett
cotransfect
nih
cell
sar
viral
envelop
e
rdrp
express
vector
revers
transcript
use
examin
express
level
envelop
e
gene
rdrp
follow
quantit
realtim
polymeras
chain
reaction
pcr
approxim
envelop
e
gene
express
reduc
sirna
express
cassett
envelop
e
two
sirna
express
cassett
rdrp
effect
block
express
gene
kamath
ahring
boutro
et
al
paddison
et
al
meng
et
al
sirna
shrna
one
sirna
site
rdrp
gene
also
examin
find
inhibit
exogen
rdrp
express
dosedepend
manner
sirna
molecul
may
use
studi
test
function
gene
sar
viru
replic
assembl
furthermor
agent
could
potenti
develop
therapeut
option
sar
treatment
meng
et
al
recent
novel
synthet
adenosin
analog
immucillina
could
inhibit
rdrp
act
nonoblig
rna
chain
termin
develop
biocryst
inc
possess
broadspectrum
activ
multipl
virus
preliminari
preclin
safeti
profil
origin
intend
treatment
hepat
c
subsequ
develop
potenti
therapi
deadli
filoviru
infect
addit
inhibit
wide
rang
rna
virus
includ
filovirus
marburg
ebola
well
cov
merscov
sarscov
develop
inhibitor
fasttrack
increas
number
therapi
recent
ebola
viru
epidem
west
africa
studi
requir
develop
treatment
hcov
infect
two
class
antivir
agent
target
sarscov
polymeras
identifi
nucleosid
analog
nonnucleosid
analog
inhibitor
xu
et
al
nucleosid
analog
inhibitor
dntp
rntp
lack
group
inhibitor
compet
nucleotid
substrat
bind
activ
site
polymeras
incorpor
elong
chain
nucleic
acid
chain
termin
result
nucleosid
inhibitor
wide
use
treatment
hbv
hcv
herpesviru
infect
de
francesco
et
al
shim
et
al
xu
et
al
xu
et
al
report
type
nucleosid
analog
inhibit
sarscov
rdrp
xu
et
al
propos
nucleosid
analog
could
inhibit
rdrp
sarscov
contain
substitu
posit
may
form
hydrogen
bond
neighbor
residu
activ
site
polymeras
addit
analysi
molecular
model
structur
sarscov
rdrp
suggest
potenti
nucleosid
inhibitor
contain
endo
sugar
pucker
conform
maintain
abil
involv
hydrogenbond
format
avoid
steric
conflict
thu
nucleosid
analog
could
found
effect
sarscov
rdrp
inhibitor
carrol
et
al
xu
et
al
present
nucleosid
analog
recogn
inhibitor
rdrp
sarscov
eg
deriv
n
dimethoxytrityl
bzdmtdc
found
inhibitori
activ
toward
sarscov
replic
addit
anoth
nucleosid
analog
accredit
antihcv
antisarscov
effect
partial
fulfil
featur
sar
rdrp
inhibitor
describ
show
activ
saracov
ec
select
index
howev
mechan
antivir
effect
still
clear
postul
might
inhibit
viral
replic
affect
thermodynam
secondari
structur
rdrp
specul
ascertain
barnard
et
al
de
clercq
recent
ebola
viru
outbreak
west
africa
necessit
vigor
effort
identifi
new
antivir
target
filovirus
led
develop
new
seri
clink
nucleosid
analog
antiebola
properti
warren
et
al
one
analog
remdesivir
good
antiebola
properti
report
inhibit
sarscov
merscov
replic
multipl
vitro
system
includ
primari
human
airway
epitheli
cell
cultur
submicromolar
ec
valu
sheahan
et
al
experiment
evalu
mous
model
sarscov
infect
show
prophylact
earli
therapeut
administr
reduc
lung
viral
load
improv
respiratori
function
along
clinic
sign
although
mechan
action
unravel
complet
gener
assum
molecul
target
rdrp
function
viral
polymeras
agostini
et
al
nonnucleosid
inhibitor
polymeras
effect
therapeut
larg
specif
current
develop
antihcv
drug
inhibitor
hydrophob
natur
act
noncompetit
manner
respect
dntp
rntp
substrat
consist
inhibitor
bind
site
differ
nucleotid
substrat
rt
nonnucleosid
analog
inhibitor
bind
hydrophob
pocket
near
polymeras
activ
site
locat
subdomain
interfac
caus
conform
chang
residu
polymeras
activ
site
displac
primer
grip
restrict
movement
thumb
hcv
bind
hydrophob
pocket
surfac
thumb
subdomain
produc
alloster
effect
interfer
conform
chang
thumb
kohlstaedt
et
al
da
et
al
dhanak
et
al
chan
et
al
love
et
al
xu
et
al
unlik
rt
sarscov
rdrp
contain
hydrophob
pocket
near
activ
site
thumb
subdomain
smaller
hcv
rdrp
essenti
part
inhibitor
bind
pocket
hcv
exist
therefor
seem
nonnucleosid
inhibitor
hcv
may
work
sarscov
polymeras
howev
differ
alloster
site
exist
sarscov
polymeras
target
develop
sarscov
polymeras
inhibitor
xu
et
al
cov
rdrp
present
excit
opportun
scientif
commun
develop
effect
therapeut
intervent
treatment
deadli
diseas
sar
mer
caus
cov
two
nsp
rdrp
activ
identifi
sar
cov
de
novo
primerdepend
polymeras
activ
respect
studi
led
reveal
mani
biochem
biophys
properti
polymeras
domain
facilit
develop
novel
therapeut
strategi
numer
approach
develop
rdrp
inhibitor
rang
small
molecul
inhibitor
flexim
acv
sirna
explor
recent
past
fundament
research
cov
rdrp
thu
prove
invalu
like
continu
combat
current
emerg
cov
infect
